Prediction of Thorough QT Trials based on Population Pharmacokinetic: Pharmacodynamic Analysis of Phase I Study QT Data

被引：0
|
作者：
Trame, Mirjam N.
Vik, Torbjorn [1 ,2 ]
Hamren, Ulrika Wahlby [3 ]
Henriksson, Karin M. [4 ,5 ]
Friberg, Lena E.
机构：
[1] Uppsala Univ, Pharmacometr Res Grp, Dept Pharmaceut Biosci, Uppsala, Sweden
[2] AstraZeneca R&D, AZ ECG Ctr, Molndal, Sweden
[3] AstraZeneca R&D, Clin Pharmacol & Pharmacometr, Molndal, Sweden
[4] Dept Med Sci, Uppsala, Sweden
[5] AstraZeneca R&D, Dept Epidemiol, Molndal, Sweden
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2013年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S78 / S79
页数：2
相关论文
共 50 条
  • [31] Establishing assay sensitivity in QT studies: experience with the use of moxifloxacin in an early phase clinical pharmacology study and comparison with its effect in a thorough QT study
    Shah, Rashmi R.
    Maison-Blanche, Pierre
    Duvauchelle, Thierry
    Robert, Philippe
    Denis, Emmanuel
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (12) : 1451 - 1459
  • [32] Establishing assay sensitivity in QT studies: experience with the use of moxifloxacin in an early phase clinical pharmacology study and comparison with its effect in a thorough QT study
    Rashmi R. Shah
    Pierre Maison-Blanche
    Thierry Duvauchelle
    Philippe Robert
    Emmanuel Denis
    [J]. European Journal of Clinical Pharmacology, 2015, 71 : 1451 - 1459
  • [33] EFFICIENCY OF DIFFERENT PHASE I STUDY DESIGNS WITH REGARD TO EXPOSURE-RESPONSE ANALYSIS OF QT DATA.
    Tsamandouras, N.
    Riley, S.
    Duvvuri, S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S113 - S113
  • [34] Concentration-QTc analysis of soticlestat in healthy adults: An alternative to a thorough QT study
    Yin, Wei
    Dote, Nobuhito
    Fukase, Hiroyuki
    Imazaki, Manami
    Shimizu, Kohei
    Takeda, Shinichi
    Darpo, Borje
    Xue, Hongqi
    Asgharnejad, Mahnaz
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024,
  • [35] A Phase 1 Thorough QT/QTc Study of Therapeutic and Supratherapeutic Doses of Belumosudil in Healthy Subjects
    Schueller, Olivier
    Lohmer, Lauren
    Xue, Hongqi
    Darpo, Borje
    Patel, Jeegar
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (10): : 1221 - 1232
  • [36] The Impact of Anemia on QT Interval: A Population Based Study
    Hunuk, Burak
    Cagac, Ozgur
    Erdogan, Okan
    Kepez, Alper
    Mutlu, Bulent
    Degertekin, Muzaffer
    Erol, Cetin
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : C146 - C146
  • [37] Four-Way Crossover Phase 1 Thorough QT Study to Assess Cardiac Safety of Domperidone and Consideration for Design and Conduct of QT/QTc Study in China
    Wang, Fangfang
    Nie, Jing
    Yang, Li
    Yang, Zhenhua
    Xu, Lin
    Wang, Liqun
    Liao, Huimin
    Li, Mengyu
    Wang, Ping
    Li, Gailing
    Li, Haiyan
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (06): : 734 - 743
  • [38] NALOXEGOL CONCENTRATION-QT ANALYSIS FROM THOROUGH QT STUDY TO PREDICT QTCF INTERVAL PROLONGATION WITH PRESENCE OF DRUG-DRUG INTERACTION
    Xu, H.
    Li, J.
    Al-Huniti, N.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S29 - S29
  • [39] Consideration of QT/QTc interval data in a phase I study in patients with advanced cancer.
    Varterasian, M
    Fingert, H
    Agin, M
    Meyer, M
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (17) : 5967 - 5968
  • [40] A Population Pharmacokinetic and Pharmacodynamic Analysis of RP5063 Phase 2 Study Data in Patients with Schizophrenia or Schizoaffective Disorder
    Cantillon, Marc
    Ings, Robert
    Prakash, Arul
    Bhat, Laxminarayan
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2018, 43 (05) : 573 - 585
12345